Latest Breaking News On - Medicare partd beneficiaries - Page 1 : comparemela.com

CDC report highlights urgent need for guideline adherence in prescribing antifungal medications

The CDC's study on Medicare Part D beneficiaries reveals high prescription rates and costs for topical antifungal medications, emphasizing the need for proper prescribing guidelines amid rising antimicrobial-resistant fungal infections.

United statesSanchari sinha duttaUs centers for diseaseCenters for medicare medicaid servicesDisease controlMortality weeklyTopical antifungal prescribingMedicare partd beneficiariesImage creditSouth asiaMedicaid servicesPrimary care

12 8 percent of unique prescribers prescribed topical antifungals in 2021

12 8 percent of unique prescribers prescribed topical antifungals in 2021
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United statesKaitlin benedictUs centers for diseaseDisease controlPrevention morbidityMortality weeklyTopical antifungal prescribingMedicare partd beneficiariesMortality weekly report

Guest Opinion: Diabetes patients deserve a better deal on insulin

No matter how many lobbyists big pharma sends to Washington I am always going to stand up for the health care of Minnesotans.

United statesDiabetes patientsMedicare partd beneficiariesSen amy klobucharFl minnBetter deal on insulinHealth care of minnesotansManufacturers increased prices

PCMA Files Motion to Vacate Effective Date for Rebate Rule

Rebate Rule Implementation Date Would Bring Chaos to Medicare Part D Program January 26, 2021 (Washington, D.C.) The Pharmaceutical Care Management Association (PCMA) has filed a motion for summary judgment to vacate the effective date of the Trump Administration’s rebate rule. The motion for summary judgment, filed in the U.S. District Court for the District of Columbia, seeks to vacate the January 1, 2022 effective date for the rebate rule with respect to Part D. The motion is vitally important to ensuring the stability of the Medicare Part D program as the Biden Administration reviews the Trump Administration’s “midnight regulations” and PCMA proceeds with litigation to revoke the rule in its entirety.

District of columbiaUnited statesAvalere healthCenters for medicare medicaid servicesHuman servicesCare management associationOffice of inspectorUs department of healthHuman services office of inspectorTrump administrationUs district courtOffice of the actuaryBiden administrationBetter medicare allianceCongressional budget officeGovernment accountability office